Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Operating Margin Over TimeContracting
Percentile Rank36
3Y CAGR+124.9%
5Y CAGR-5.1%
Year-over-Year Change
Operating income as a percentage of revenue
3Y CAGR
+124.9%/yr
vs -60.7%/yr prior
5Y CAGR
-5.1%/yr
Recent acceleration
Acceleration
+185.6pp
Accelerating
Percentile
P36
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | 17.61% | +230.2% |
| 2024 | -13.53% | -248.7% |
| 2023 | 9.09% | +487.7% |
| 2022 | 1.55% | -96.4% |
| 2021 | 42.99% | +87.5% |
| 2020 | 22.93% | -96.6% |
| 2019 | 670.99% | +930.5% |
| 2018 | 65.11% | +35.0% |
| 2017 | 48.25% | +19.8% |
| 2016 | 40.27% | - |